Cargando…
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
BACKGROUND: Hyponatremia based on syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH) is observed in up to 15% of patients with small cell lung cancer (SCLC). The electrolyte imbalance is associated with a high morbidity and mortality and often delays appropriate treatment. Managem...
Autores principales: | Petereit, Claudia, Zaba, Okan, Teber, Ishak, Lüders, Heike, Grohé, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851291/ https://www.ncbi.nlm.nih.gov/pubmed/23987478 http://dx.doi.org/10.1186/1471-2466-13-55 |
Ejemplares similares
-
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
por: De las Peñas, Ramón, et al.
Publicado: (2015) -
The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
por: Ren, Peng, et al.
Publicado: (2021) -
Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia Resulting from SIADH Following Pituitary Surgery
por: Kleindienst, Andrea, et al.
Publicado: (2020) -
THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023) -
Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH
por: Willemsen, Ruben H, et al.
Publicado: (2016)